At Lawson’s hub of research into aging and neurogenerative diseases, we weave together world-changing science with clinical practice.
Our determined team of experts seeks to help people live better and more independently throughout their lifespans, and to halt the rising toll that dementia is taking on Canadians.
It’s why we’re national and global leaders in:
- Seeking earlier, faster ways to diagnose and predict dementia and related neurodegenerative diseases through innovative biomarker tests and advanced brain imaging
- Leading rigorous trials of new medications that could delay or halt – or potentially even reverse – cognitive impairment
- Understanding the link between cognition and mobility, osteoporosis and bone health, falls and frailty,
- Helping translate our findings to patients, caregivers, clinicians and allied health professionals.
Our half-century legacy of groundbreaking research is bolstered by major, multi-year grants from national funding agencies and philanthropists, who recognize the depth of our expertise and the breadth of our partnerships.
We lead the world in researching diseases associated with aging. Read on to see where we can lead you.
